Crossref journal-article
Elsevier BV
The Lancet (78)
Bibliography

Buyse, M., Thirion, P., Carlson, R. W., Burzykowski, T., Molenberghs, G., & Piedbois, P. (2000). Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. The Lancet, 356(9227), 373–378.

Authors 6
  1. Marc Buyse (first)
  2. Pierre Thirion (additional)
  3. Robert W Carlson (additional)
  4. Tomasz Burzykowski (additional)
  5. Geert Molenberghs (additional)
  6. Pascal Piedbois (additional)
References 27 Referenced 334
  1. Food and Drug Administration. Reinventing the regulation of cancer drugs: accelerating approval and expanding access. Washington DC: National Performance Review, March 1996.
  2. 10.1177/009286159803200105 / Drug Inf J / Faster access to drugs for serious or life‐threatening illnesses through use of the accelerated approval regulation in the United States by Cocchetto (1998)
  3. 10.1002/sim.4780130906 / Stat Med / Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research by Fleming (1994)
  4. 10.1056/NEJM199304083281409 / N Engl J Med / Treatment of non‐Hodgkin's lymphoma by Armitage (1993)
  5. 10.1056/NEJM199309303291402 / N Eng J Med / A predictive model for aggressive non‐Hodgkin's lymphoma (1993)
  6. 10.7326/0003-4819-122-4-199502150-00003 / Ann Intern Med / Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon‐a therapy by Kantarjian (1995)
  7. 10.1001/jama.1984.03350190024013 / JAMA / Does response make a difference in patient survival? by Oye (1984)
  8. 10.1200/JCO.1992.10.6.896 / J Clin Oncol / Modulation of 5‐fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate (1992)
  9. 10.1200/JCO.1994.12.5.960 / J Clin Oncol / Meta‐analysis of randomized trials testing the biochemical modulation of 5‐fluorouracil by methotrexate in metastatic colorectal cancer (1994)
  10. 10.1200/JCO.1998.16.1.301 / J Clin Oncol / Efficacy of intravenous continuous infusion of 5‐fluorouracil compared with bolus administration in patients with advanced colorectal cancer (1998)
  11. 10.1093/jnci/88.5.252 / J Natl Cancer Inst / Reappraisal of hepatic arterial infusion in the treatment of nonresectable liver metastases from colorectal cancer (1996)
  12. {'key': '10.1016/S0140-6736(00)02528-9_bib12', 'series-title': 'WHO Handbook for Reporting results of Cancer Treatment WHO Offset Publication number 48', 'year': '1979'} / WHO Handbook for Reporting results of Cancer Treatment WHO Offset Publication number 48 (1979)
  13. 10.1200/JCO.1983.1.11.710 / J Clin Oncol / Analysis of survival by tumor response by Anderson (1983)
  14. 10.1002/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V / Stat Med / On the relationship between response to treatment and survival time by Buyse (1996)
  15. 10.2307/2533853 / Biometrics / Validation of surrogate endpoints in randomized clinical trials by Buyse (1998)
  16. {'key': '10.1016/S0140-6736(00)02528-9_bib16', 'series-title': 'Proceedings of the Biopharmaceutical Section', 'first-page': '40', 'article-title': 'Validation of surrogate endpoints in multiple randomized clinical trials with failure‐time endpoints', 'author': 'Burzykowski', 'year': '1999'} / Proceedings of the Biopharmaceutical Section / Validation of surrogate endpoints in multiple randomized clinical trials with failure‐time endpoints by Burzykowski (1999)
  17. 10.1093/biostatistics/1.1.49 / Biostatistics / The validation of surrogate endpoints in meta‐analyses of randomized experiments by Buyse (2000)
  18. 10.1002/sim.4780110204 / Stat Med / Statistical validation of intermediate endpoints for chronic diseases by Freedman (1992)
  19. 10.1002/(SICI)1097-0258(19970715)16:13<1515::AID-SIM572>3.0.CO;2-1 / Stat Med / Estimating the proportion of treatment effect explained by a surrogate marker by Lin (1997)
  20. 10.1038/bjc.1994.345 / Br J Cancer / The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer by Graf (1994)
  21. 10.1016/S0197-2456(83)80011-7 / Control Clin Trials / Comparing survival of responders and nonresponders after treatment: a potential source of confusion in interpreting cancer clinical trials by Weiss (1983)
  22. {'key': '10.1016/S0140-6736(00)02528-9_bib22', 'first-page': '1155', 'article-title': 'Food and Drug Administration requirements for approval of new anticancer drugs', 'volume': '69', 'author': 'Johnson', 'year': '1985', 'journal-title': 'Cancer Treat Rep'} / Cancer Treat Rep / Food and Drug Administration requirements for approval of new anticancer drugs by Johnson (1985)
  23. 10.1002/1097-0142(19801001)46:7<1536::AID-CNCR2820460707>3.0.CO;2-K / Cancer / Survival and response to chemotherapy for advanced colorectal adenocarcinoma by Lavin (1980)
  24. Molenberghs G, Buyse M, Geys H, Renard D, Burzykowski T. Statistical challenges in the evaluation of surrogate endpoints in randomized trials. Stat Med (in press). (10.1016/S0197-2456(02)00236-2)
  25. 10.1200/JCO.1993.11.10.1879 / J Clin Oncol / The benefit of leucovorin‐modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C‐03 by Wolmark (1993)
  26. 10.1016/S0140-6736(95)90696-7 / Lancet / Efficacy of adjuvant fluorouracil and folinic acid in colon cancer (1995)
  27. 10.1200/JCO.1997.15.1.246 / J Clin Oncol / Controlled trial of fluorouracil and low‐dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer by O'Connell (1997)
Dates
Type When
Created 23 years, 1 month ago (July 25, 2002, 10:10 a.m.)
Deposited 6 years, 4 months ago (April 28, 2019, 12:21 p.m.)
Indexed 1 week, 2 days ago (Aug. 27, 2025, 12:20 p.m.)
Issued 25 years, 2 months ago (July 1, 2000)
Published 25 years, 2 months ago (July 1, 2000)
Published Print 25 years, 2 months ago (July 1, 2000)
Funders 0

None

@article{Buyse_2000, title={Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis}, volume={356}, ISSN={0140-6736}, url={http://dx.doi.org/10.1016/s0140-6736(00)02528-9}, DOI={10.1016/s0140-6736(00)02528-9}, number={9227}, journal={The Lancet}, publisher={Elsevier BV}, author={Buyse, Marc and Thirion, Pierre and Carlson, Robert W and Burzykowski, Tomasz and Molenberghs, Geert and Piedbois, Pascal}, year={2000}, month=jul, pages={373–378} }